article · Egyptian Journal of Veterinary Science
This cross-sectional study aimed to investigate feline upper respiratory tract disease (FURTD) in domestic cats, with a focus on the associated feline calicivirus (FCV) and feline herpesvirus type 1 (FHV-1). To the best of our knowledge, there are no previous studies on FCV in domestic cats in Egypt, and studies on FHV-1 are very limited. A total of 850 cats were included, signs of FURTD were detected in 101 cats in a percentage of 11.9%. Significant variations were existed among different ages and breeds. PCR targeting FHV-1 and RT-PCR targeting FCV were performed for 30 diseased cats and showed ten and eleven positive cases in a percentage of 33.3% and 36.7%, respectively. Most of the molecular identified cases existed as a singleton infection, except of two cases of mixed infection in a percentage of 6.7%. Obvious respiratory signs were detected for both viruses with a notable ocular involvement of FHV-1 infected cases and Oral lesions and tongue ulcers of FCV infected cases. Five FHV-1 strains and three FCV strains were sequenced for phylogenetic analysis on both the genomic and protein levels which are presented in the results section. In conclusion, FURTD is prevalent among cats in the study area and FHV-1 and/or FCV infection exists in a considerable proportion of these cases which are associated with variable clinical signs and case fatality rates. In addition, phylogenetic analysis is important for traceability and detection of relationship between these pathogens.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.21608/ejvs.2025.400505.2949
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.